BMEA
Price
$2.29
Change
+$0.23 (+11.17%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
73.27M
6 days until earnings call
KROS
Price
$14.41
Change
+$0.11 (+0.77%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
563.41M
7 days until earnings call
Ad is loading...

BMEA vs KROS

Header iconBMEA vs KROS Comparison
Open Charts BMEA vs KROSBanner chart's image
Biomea Fusion
Price$2.29
Change+$0.23 (+11.17%)
Volume$3.71K
Capitalization73.27M
Keros Therapeutics
Price$14.41
Change+$0.11 (+0.77%)
Volume$6.26K
Capitalization563.41M
BMEA vs KROS Comparison Chart
Loading...
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMEA vs. KROS commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Buy and KROS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BMEA: $2.06 vs. KROS: $14.30)
Brand notoriety: BMEA and KROS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 105% vs. KROS: 107%
Market capitalization -- BMEA: $73.27M vs. KROS: $563.41M
BMEA [@Biotechnology] is valued at $73.27M. KROS’s [@Biotechnology] market capitalization is $563.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 1 FA rating(s) are green whileKROS’s FA Score has 0 green FA rating(s).

  • BMEA’s FA Score: 1 green, 4 red.
  • KROS’s FA Score: 0 green, 5 red.
According to our system of comparison, BMEA is a better buy in the long-term than KROS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 6 TA indicator(s) are bullish while KROS’s TA Score has 5 bullish TA indicator(s).

  • BMEA’s TA Score: 6 bullish, 2 bearish.
  • KROS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BMEA is a better buy in the short-term than KROS.

Price Growth

BMEA (@Biotechnology) experienced а +29.56% price change this week, while KROS (@Biotechnology) price change was +5.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

BMEA is expected to report earnings on Aug 04, 2025.

KROS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($563M) has a higher market cap than BMEA($73.3M). KROS YTD gains are higher at: -9.665 vs. BMEA (-46.907). BMEA has higher annual earnings (EBITDA): -149.62M vs. KROS (-185.82M). KROS has more cash in the bank: 560M vs. BMEA (88M). BMEA has less debt than KROS: BMEA (9.57M) vs KROS (18.9M). KROS has higher revenues than BMEA: KROS (3.55M) vs BMEA (0).
BMEAKROSBMEA / KROS
Capitalization73.3M563M13%
EBITDA-149.62M-185.82M81%
Gain YTD-46.907-9.665485%
P/E RatioN/AN/A-
Revenue03.55M-
Total Cash88M560M16%
Total Debt9.57M18.9M51%
TECHNICAL ANALYSIS
Technical Analysis
BMEAKROS
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 24 days ago
90%
Bearish Trend 24 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMPAX25.18N/A
N/A
Fidelity Advisor Mid Cap Value A
PWTYX46.56N/A
N/A
UBS US Allocation P
LCBEX30.04N/A
N/A
ClearBridge Dividend Strategy IS
QICLX14.46N/A
N/A
AQR International Multi-Style I
VIOAX9.19N/A
N/A
VELA Income Opportunities A

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with ARCT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+5.64%
ARCT - BMEA
51%
Loosely correlated
+3.78%
PRME - BMEA
33%
Loosely correlated
+4.14%
BAIVF - BMEA
32%
Poorly correlated
N/A
IDYA - BMEA
32%
Poorly correlated
+0.91%
KROS - BMEA
31%
Poorly correlated
+2.95%
More